8-K 1 d55210d8k.htm 8-K 8-K





Washington, D.C. 20549







Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 10, 2019



Aravive, Inc.

(Exact name of registrant as specified in its charter)




Delaware   001-36361   26-4106690
(State or other jurisdiction
of incorporation)
File Number)
  (IRS Employer
Identification No.)

LyondellBasell Tower

1221 McKinney Street, Suite 3200

Houston, Texas 77010

(Address of principal executive offices, including zip code)

(936) 355-1910

(Registrant’s telephone number, including area code)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class




Name of each exchange
on which registered

Common stock, par value $0.0001 per share   ARAV   Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☒




Item 5.08

Shareholder Director Nominations

On July 10, 2019, the Board of Directors of Aravive, Inc. (the “Company”) approved September 12, 2019 as the date of its 2019 Annual Meeting of Stockholders (the “Annual Meeting”). The Board also approved July 17, 2019 as the record date for stockholders entitled to notice of and to vote at the Annual Meeting.

Because the Company did not hold an annual meeting last year and instead held a special meeting of stockholders in October 2018, the Company is required to provide a deadline for the receipt of stockholder proposals for inclusion in the Company’s proxy materials for the 2019 Annual Meeting. The deadline for nominations or proposals, including any notice on Schedule 14N, will be July 26, 2019. Any proposal submitted to the Company after July 26, 2019 will not be considered timely and will be excluded from the Company’s proxy materials. Proposals of stockholders must also comply with rules of the Securities and Exchange (the “SEC”) regarding the inclusion of stockholder proposals in proxy materials and the Company may omit any proposal from its proxy materials that does not comply with the SEC’s rules.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: July 11, 2019    



    By:   /s/ Jay P. Shepard
    Name:   Jay P. Shepard
    Title:   Chief Executive Officer